171 related articles for article (PubMed ID: 20199686)
1. Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.
Agelopoulos K; Greve B; Schmidt H; Pospisil H; Kurtz S; Bartkowiak K; Andreas A; Wieczorek M; Korsching E; Buerger H; Brandt B
BMC Cancer; 2010 Mar; 10():78. PubMed ID: 20199686
[TBL] [Abstract][Full Text] [Related]
2. The phenotypic radiation resistance of CD44+/CD24(-or low) breast cancer cells is mediated through the enhanced activation of ATM signaling.
Yin H; Glass J
PLoS One; 2011; 6(9):e24080. PubMed ID: 21935375
[TBL] [Abstract][Full Text] [Related]
3. Metalloprotease-dependent activation of EGFR modulates CD44
Wise R; Zolkiewska A
Breast Cancer Res Treat; 2017 Nov; 166(2):421-433. PubMed ID: 28791489
[TBL] [Abstract][Full Text] [Related]
4. [Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway].
Lu ZH; Jia J; Ren J; Ma B; DI LJ; Song GH
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):480-5. PubMed ID: 18931709
[TBL] [Abstract][Full Text] [Related]
5. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
Calaf GM; Ponce-Cusi R; Abarca-Quinones J
Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
[TBL] [Abstract][Full Text] [Related]
6. [Different coexisting genotypes in the breast cancer cell line MDA-MB-468].
Agelopoulos K; Schmidt H; Korsching E; Buerger H; Brandt B
Pathologe; 2008 Nov; 29 Suppl 2():333-7. PubMed ID: 18751981
[TBL] [Abstract][Full Text] [Related]
7. Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype.
Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Vellon L; Menendez JA
Cell Cycle; 2011 Nov; 10(22):3871-85. PubMed ID: 22127234
[TBL] [Abstract][Full Text] [Related]
8. Effects of normothermic microwave irradiation on CD44
Asano M; Tanaka S; Sakaguchi M
Biosci Biotechnol Biochem; 2020 Jan; 84(1):103-110. PubMed ID: 31559912
[TBL] [Abstract][Full Text] [Related]
9. [Isolation of CD44+/CD24 -/low and side population cells from MDA-MB-453 cells and the analysis of their activation of Wnt and Notch pathway].
Li X; Ren J
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):471-5. PubMed ID: 18931707
[TBL] [Abstract][Full Text] [Related]
10. VGLL1 stabilization of cytoplasmic TAZ promotes EGFR expression and maintains tumor initiating cells in breast cancer independent of TEAD.
Parimita S; Das A; Samanta S
Cell Signal; 2024 Jun; 118():111120. PubMed ID: 38417636
[TBL] [Abstract][Full Text] [Related]
11. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
[TBL] [Abstract][Full Text] [Related]
12. The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.
Giatromanolaki A; Sivridis E; Fiska A; Koukourakis MI
Med Oncol; 2011 Sep; 28(3):745-52. PubMed ID: 20405247
[TBL] [Abstract][Full Text] [Related]
13. CD44(+)/CD24(-) breast cancer cells exhibit phenotypic reversion in three-dimensional self-assembling peptide RADA16 nanofiber scaffold.
Mi K; Xing Z
Int J Nanomedicine; 2015; 10():3043-53. PubMed ID: 25945050
[TBL] [Abstract][Full Text] [Related]
14. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
15. Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer.
Buess M; Rajski M; Vogel-Durrer BM; Herrmann R; Rochlitz C
Neoplasia; 2009 Oct; 11(10):987-1002. PubMed ID: 19794958
[TBL] [Abstract][Full Text] [Related]
16. Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines.
Meyer MJ; Fleming JM; Ali MA; Pesesky MW; Ginsburg E; Vonderhaar BK
Breast Cancer Res; 2009; 11(6):R82. PubMed ID: 19906290
[TBL] [Abstract][Full Text] [Related]
17. The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G; Bendahl PO; Ringnér M; Saal LH; Gruvberger-Saal SK; Lövgren K; Grabau D; Fernö M; Borg A; Hegardt C
Breast Cancer Res; 2008; 10(3):R53. PubMed ID: 18559090
[TBL] [Abstract][Full Text] [Related]
18. Association of CD44
Chekhun VF; Lukianova NY; Chekhun SV; Bezdieniezhnykh NO; Zadvorniy TV; Borikun TV; Polishchuk LZ; Klyusov OМ
Exp Oncol; 2017 Sep; 39(3):203-211. PubMed ID: 28967645
[TBL] [Abstract][Full Text] [Related]
19. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
Rappa G; Lorico A
Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
